| Literature DB >> 31939490 |
Eva C Coopmans1, Sebastiaan W F van Meyel1, Aart J van der Lely1, Sebastian J C M M Neggers1.
Abstract
Advances in combination medical treatment have offer new perspectives for acromegaly patients with persistent disease activity despite receiving the available medical monotherapies. The outcomes of combination medical treatment may reflect both additive and synergistic effects. This review focuses on combination medical treatment and its current position in acromegaly, based on clinical studies evaluating the efficacy and safety of combined medical treatment(s) and our own experiences with combination therapy. Arch Endocrinol Metab. 2019;63(6):646-52.Entities:
Mesh：
Substances：
Year: 2019 PMID： 31939490 DOI： 10.20945/2359-3997000000195
Source DB: PubMed Journal: Arch Endocrinol Metab ISSN： 2359-3997 Impact factor: 2.309